Earlier detection of brain metastases could increase the chances of successful surgical removal of the tumors, says Sanford Simon, whose Laboratory of Cellular Biophysics previously
identified the genetic driver behind fibrolamellar.
Not exact matches
Genomics provides the ability to
identify and target
genetic drivers of disease.
As the first step in a next generation knowledge system for cancer, the GDC enables and accelerates efforts to
identify both high - and low - frequency cancer
driver mutations, assists in revealing the
genetic determinants of response to therapy, and informs the composition of clinical trial cohorts.
Using
genetic and epigenetic analyses coupled with powerful perturbation technologies to test gene functions in human cells and mouse models, we hope to
identify the critical
drivers of this disease and the basis for therapeutic responses.
First Major Gene Mutation for Hereditary Prostate Cancer Found After a 20 - year quest to find a
genetic driver for prostate cancer that strikes men at younger ages and runs in families, researchers have
identified a rare, inherited mutation linked to a significantly higher risk of the disease.
Here we present a rapid genome - wide approach capable of
identifying multiple
genetic drivers of medically relevant phenotypes within malaria parasites via a single experiment at single gene or allele resolution.
Here, we performed forward
genetic screening in mice using Sleeping Beauty transposon mutagenesis to
identify candidate BC
driver genes in an unbiased manner, using a stabilized N - terminal truncated β - catenin gene as a sensitizer.